ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Drug-Device Combination Products Market Report & Forecast 2023-2029
Published Date: December 2023
|
Report Code: QYRE-Auto-8W16340
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and India Drug Device Combination Products Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Drug-Device Combination Products Market Report & Forecast 2023-2029

Code: QYRE-Auto-8W16340
Report
December 2023
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Novo Nordisk
Eli Lilly
Astrazeneca plc
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic Inc
Mylan NV
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma

and India Drug-Device Combination Products Market Size

The global Drug-Device Combination Products revenue was US$ 35200 million in 2022 and is forecast to a readjusted size of US$ 53720 million by 2029 with a CAGR of 6.2% during the review period (2023-2029).

and India Drug-Device Combination Products Market

and India Drug-Device Combination Products Market

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
In India, the Drug-Device Combination Products revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.
In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.
This report focuses on global and India Drug-Device Combination Products market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Drug-Device Combination Products will continue to grow rapidly in the future.
Global Drug-Device Combination Products Scope and Market Size
Drug-Device Combination Products market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Drug-Device Combination Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Drug-Device Combination Products market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Drug-Device Combination Products Market Report

Report Metric Details
Report Name and India Drug-Device Combination Products Market
Forecasted market size in 2029 US$ 53720 million
CAGR 6.2%
Forecasted years 2023 - 2029
Segment by Type
  • Drug-Coated Device
  • Prefilled Drug Delivery Systems
  • Nebulizer and Inhaler
  • Transdermal Delivery System
  • Others
Segment by Application
  • Hospital andClinic
  • Retail Pharmacies
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim, Medtronic, Mylan, 3M, Hisamitsu, Smith & Nephew, Molnlycke, Teleflex, BD, Lepu Medical, MicroPort, Terumo, B. Braun, Antares Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Drug-Device Combination Products Market size in 2029?

Ans: The and India Drug-Device Combination Products Market size in 2029 will be US$ 53720 million.

What is the market share of major companies in and India Drug-Device Combination Products Market?

Ans: The top 3 companies hold a share about 32%.

What is the and India Drug-Device Combination Products Market share by region?

Ans: North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Drug-Device Combination Products Market report?

Ans: The main players in the and India Drug-Device Combination Products Market are GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim, Medtronic, Mylan, 3M, Hisamitsu, Smith & Nephew, Molnlycke, Teleflex, BD, Lepu Medical, MicroPort, Terumo, B. Braun, Antares Pharma

What are the Application segmentation covered in the and India Drug-Device Combination Products Market report?

Ans: The Applications covered in the and India Drug-Device Combination Products Market report are Hospital andClinic, Retail Pharmacies, Other

What are the Type segmentation covered in the and India Drug-Device Combination Products Market report?

Ans: The Types covered in the and India Drug-Device Combination Products Market report are Drug-Coated Device, Prefilled Drug Delivery Systems, Nebulizer and Inhaler, Transdermal Delivery System, Others

1 Study Coverage
1.1 Drug-Device Combination Products Product Introduction
1.2 Global Drug-Device Combination Products Outlook 2018 VS 2022 VS 2029
1.2.1 Global Drug-Device Combination Products Market Size for the Year 2018-2029
1.2.2 India Drug-Device Combination Products Market Size for the Year 2018-2029
1.3 Drug-Device Combination Products Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Drug-Device Combination Products in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Drug-Device Combination Products Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Drug-Device Combination Products Market Dynamics
1.4.1 Drug-Device Combination Products Industry Trends
1.4.2 Drug-Device Combination Products Market Drivers
1.4.3 Drug-Device Combination Products Market Challenges
1.4.4 Drug-Device Combination Products Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Drug-Device Combination Products by Type
2.1 Drug-Device Combination Products Market Segment by Type
2.1.1 Drug-Coated Device
2.1.2 Prefilled Drug Delivery Systems
2.1.3 Nebulizer and Inhaler
2.1.4 Transdermal Delivery System
2.1.5 Others
2.2 Global Drug-Device Combination Products Market Size by Type (2018, 2022 & 2029)
2.3 Global Drug-Device Combination Products Market Size by Type (2018-2029)
2.4 India Drug-Device Combination Products Market Size by Type (2018, 2022 & 2029)
2.5 India Drug-Device Combination Products Market Size by Type (2018-2029)
3 Drug-Device Combination Products by Application
3.1 Drug-Device Combination Products Market Segment by Application
3.1.1 Hospital andClinic
3.1.2 Retail Pharmacies
3.1.3 Other
3.2 Global Drug-Device Combination Products Market Size by Application (2018, 2022 & 2029)
3.3 Global Drug-Device Combination Products Market Size by Application (2018-2029)
3.4 India Drug-Device Combination Products Market Size by Application (2018, 2022 & 2029)
3.5 India Drug-Device Combination Products Market Size by Application (2018-2029)
4 Global Drug-Device Combination Products Competitor Landscape by Company
4.1 Global Drug-Device Combination Products Market Size by Company
4.1.1 Global Key Companies of Drug-Device Combination Products, Ranked by Revenue (2022)
4.1.2 Global Drug-Device Combination Products Revenue by Player (2018-2023)
4.2 Global Drug-Device Combination Products Concentration Ratio (CR)
4.2.1 Drug-Device Combination Products Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Drug-Device Combination Products in 2022
4.2.3 Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Drug-Device Combination Products Head office and Area Served
4.4 Global Key Players of Drug-Device Combination Products, Product and Application
4.5 Global Key Players of Drug-Device Combination Products, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Drug-Device Combination Products Market Size by Company
4.7.1 Key Players of Drug-Device Combination Products in India, Ranked by Revenue (2022)
4.7.2 India Drug-Device Combination Products Revenue by Players (2021, 2022 & 2023)
5 Global Drug-Device Combination Products Market Size by Region
5.1 Global Drug-Device Combination Products Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Drug-Device Combination Products Market Size by Region (2018-2029)
5.2.1 Global Drug-Device Combination Products Market Size by Region: 2018-2023
5.2.2 Global Drug-Device Combination Products Market Size by Region (2024-2029)
6 Americas
6.1 Americas Drug-Device Combination Products Market Size YoY Growth 2018-2029
6.2 Americas Drug-Device Combination Products Market Size by Type
6.2.1 Americas Drug-Device Combination Products Market Size by Type (2018-2023)
6.2.2 Americas Drug-Device Combination Products Market Size by Type (2024-2029)
6.2.3 Americas Drug-Device Combination Products Market Share by Type (2018-2029)
6.3 Americas Drug-Device Combination Products Market Size by Application
6.3.1 Americas Drug-Device Combination Products Market Size by Application (2018-2023)
6.3.2 Americas Drug-Device Combination Products Market Size by Application (2024-2029)
6.3.3 Americas Drug-Device Combination Products Market Share by Application (2018-2029)
6.4 Americas Drug-Device Combination Products Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Drug-Device Combination Products Market Size YoY Growth 2018-2029
7.2 EMEA Drug-Device Combination Products Market Size by Type
7.2.1 EMEA Drug-Device Combination Products Market Size by Type (2018-2023)
7.2.2 EMEA Drug-Device Combination Products Market Size by Type (2024-2029)
7.2.3 EMEA Drug-Device Combination Products Market Share by Type (2018-2029)
7.3 EMEA Drug-Device Combination Products Market Size by Application
7.3.1 EMEA Drug-Device Combination Products Market Size by Application (2018-2023)
7.3.2 EMEA Drug-Device Combination Products Market Size by Application (2024-2029)
7.3.3 EMEA Drug-Device Combination Products Market Share by Application (2018-2029)
7.4 EMEA Drug-Device Combination Products Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Drug-Device Combination Products Market Size YoY Growth 2018-2029
8.2 China Drug-Device Combination Products Market Size by Type
8.2.1 China Drug-Device Combination Products Market Size by Type (2018-2023)
8.2.2 China Drug-Device Combination Products Market Size by Type (2024-2029)
8.2.3 China Drug-Device Combination Products Market Share by Type (2018-2029)
8.3 China Drug-Device Combination Products Market Size by Application
8.3.1 China Drug-Device Combination Products Market Size by Application (2018-2023)
8.3.2 China Drug-Device Combination Products Market Size by Application (2024-2029)
8.3.3 China Drug-Device Combination Products Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Drug-Device Combination Products Market Size YoY Growth 2018-2029
9.2 APAC Drug-Device Combination Products Market Size by Type
9.2.1 APAC Drug-Device Combination Products Market Size by Type (2018-2023)
9.2.2 APAC Drug-Device Combination Products Market Size by Type (2024-2029)
9.2.3 APAC Drug-Device Combination Products Market Share by Type (2018-2029)
9.3 APAC Drug-Device Combination Products Market Size by Application
9.3.1 APAC Drug-Device Combination Products Market Size by Application (2018-2023)
9.3.2 APAC Drug-Device Combination Products Market Size by Application (2024-2029)
9.3.3 APAC Drug-Device Combination Products Market Share by Application (2018-2029)
9.4 APAC Drug-Device Combination Products Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 GSK
10.1.1 GSK Company Details
10.1.2 GSK Business Overview
10.1.3 GSK Drug-Device Combination Products Introduction
10.1.4 GSK Revenue in Drug-Device Combination Products Business (2018-2023)
10.1.5 GSK Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Company Details
10.2.2 Novo Nordisk Business Overview
10.2.3 Novo Nordisk Drug-Device Combination Products Introduction
10.2.4 Novo Nordisk Revenue in Drug-Device Combination Products Business (2018-2023)
10.2.5 Novo Nordisk Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Details
10.3.2 Eli Lilly Business Overview
10.3.3 Eli Lilly Drug-Device Combination Products Introduction
10.3.4 Eli Lilly Revenue in Drug-Device Combination Products Business (2018-2023)
10.3.5 Eli Lilly Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Details
10.4.2 AstraZeneca Business Overview
10.4.3 AstraZeneca Drug-Device Combination Products Introduction
10.4.4 AstraZeneca Revenue in Drug-Device Combination Products Business (2018-2023)
10.4.5 AstraZeneca Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Details
10.5.2 Sanofi Business Overview
10.5.3 Sanofi Drug-Device Combination Products Introduction
10.5.4 Sanofi Revenue in Drug-Device Combination Products Business (2018-2023)
10.5.5 Sanofi Recent Development
10.6 Boston Scientific
10.6.1 Boston Scientific Company Details
10.6.2 Boston Scientific Business Overview
10.6.3 Boston Scientific Drug-Device Combination Products Introduction
10.6.4 Boston Scientific Revenue in Drug-Device Combination Products Business (2018-2023)
10.6.5 Boston Scientific Recent Development
10.7 Abbott
10.7.1 Abbott Company Details
10.7.2 Abbott Business Overview
10.7.3 Abbott Drug-Device Combination Products Introduction
10.7.4 Abbott Revenue in Drug-Device Combination Products Business (2018-2023)
10.7.5 Abbott Recent Development
10.8 Boehringer Ingelheim
10.8.1 Boehringer Ingelheim Company Details
10.8.2 Boehringer Ingelheim Business Overview
10.8.3 Boehringer Ingelheim Drug-Device Combination Products Introduction
10.8.4 Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2018-2023)
10.8.5 Boehringer Ingelheim Recent Development
10.9 Medtronic
10.9.1 Medtronic Company Details
10.9.2 Medtronic Business Overview
10.9.3 Medtronic Drug-Device Combination Products Introduction
10.9.4 Medtronic Revenue in Drug-Device Combination Products Business (2018-2023)
10.9.5 Medtronic Recent Development
10.10 Mylan
10.10.1 Mylan Company Details
10.10.2 Mylan Business Overview
10.10.3 Mylan Drug-Device Combination Products Introduction
10.10.4 Mylan Revenue in Drug-Device Combination Products Business (2018-2023)
10.10.5 Mylan Recent Development
10.11 3M
10.11.1 3M Company Details
10.11.2 3M Business Overview
10.11.3 3M Drug-Device Combination Products Introduction
10.11.4 3M Revenue in Drug-Device Combination Products Business (2018-2023)
10.11.5 3M Recent Development
10.12 Hisamitsu
10.12.1 Hisamitsu Company Details
10.12.2 Hisamitsu Business Overview
10.12.3 Hisamitsu Drug-Device Combination Products Introduction
10.12.4 Hisamitsu Revenue in Drug-Device Combination Products Business (2018-2023)
10.12.5 Hisamitsu Recent Development
10.13 Smith & Nephew
10.13.1 Smith & Nephew Company Details
10.13.2 Smith & Nephew Business Overview
10.13.3 Smith & Nephew Drug-Device Combination Products Introduction
10.13.4 Smith & Nephew Revenue in Drug-Device Combination Products Business (2018-2023)
10.13.5 Smith & Nephew Recent Development
10.14 Molnlycke
10.14.1 Molnlycke Company Details
10.14.2 Molnlycke Business Overview
10.14.3 Molnlycke Drug-Device Combination Products Introduction
10.14.4 Molnlycke Revenue in Drug-Device Combination Products Business (2018-2023)
10.14.5 Molnlycke Recent Development
10.15 Teleflex
10.15.1 Teleflex Company Details
10.15.2 Teleflex Business Overview
10.15.3 Teleflex Drug-Device Combination Products Introduction
10.15.4 Teleflex Revenue in Drug-Device Combination Products Business (2018-2023)
10.15.5 Teleflex Recent Development
10.16 BD
10.16.1 BD Company Details
10.16.2 BD Business Overview
10.16.3 BD Drug-Device Combination Products Introduction
10.16.4 BD Revenue in Drug-Device Combination Products Business (2018-2023)
10.16.5 BD Recent Development
10.17 Lepu Medical
10.17.1 Lepu Medical Company Details
10.17.2 Lepu Medical Business Overview
10.17.3 Lepu Medical Drug-Device Combination Products Introduction
10.17.4 Lepu Medical Revenue in Drug-Device Combination Products Business (2018-2023)
10.17.5 Lepu Medical Recent Development
10.18 MicroPort
10.18.1 MicroPort Company Details
10.18.2 MicroPort Business Overview
10.18.3 MicroPort Drug-Device Combination Products Introduction
10.18.4 MicroPort Revenue in Drug-Device Combination Products Business (2018-2023)
10.18.5 MicroPort Recent Development
10.19 Terumo
10.19.1 Terumo Company Details
10.19.2 Terumo Business Overview
10.19.3 Terumo Drug-Device Combination Products Introduction
10.19.4 Terumo Revenue in Drug-Device Combination Products Business (2018-2023)
10.19.5 Terumo Recent Development
10.20 B. Braun
10.20.1 B. Braun Company Details
10.20.2 B. Braun Business Overview
10.20.3 B. Braun Drug-Device Combination Products Introduction
10.20.4 B. Braun Revenue in Drug-Device Combination Products Business (2018-2023)
10.20.5 B. Braun Recent Development
10.21 Antares Pharma
10.21.1 Antares Pharma Company Details
10.21.2 Antares Pharma Business Overview
10.21.3 Antares Pharma Drug-Device Combination Products Introduction
10.21.4 Antares Pharma Revenue in Drug-Device Combination Products Business (2018-2023)
10.21.5 Antares Pharma Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
GSK
Novo Nordisk
Eli Lilly
Astrazeneca plc
Sanofi
Boston Scientific
Abbott
Boehringer Ingelheim
Medtronic Inc
Mylan NV
3M
Hisamitsu
Smith & Nephew
Molnlycke
Teleflex
BD
Lepu Medical
MicroPort
Terumo
B. Braun
Antares Pharma
List of Tables
    Table 1. Drug-Device Combination Products Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Drug-Device Combination Products Market Trends
    Table 3. Drug-Device Combination Products Market Drivers
    Table 4. Drug-Device Combination Products Market Challenges
    Table 5. Drug-Device Combination Products Market Restraints
    Table 6. Global Drug-Device Combination Products Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Drug-Device Combination Products Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Drug-Device Combination Products Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Drug-Device Combination Products Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Drug-Device Combination Products, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Drug-Device Combination Products Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Drug-Device Combination Products Revenue Share by Player, 2018-2023
    Table 13. Global Drug-Device Combination Products Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Drug-Device Combination Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2022)
    Table 15. Global Key Players of Drug-Device Combination Products, Headquarters and Area Served
    Table 16. Global Key Players of Drug-Device Combination Products, Product and Application
    Table 17. Global Key Players of Drug-Device Combination Products, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Drug-Device Combination Products in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Drug-Device Combination Products Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Drug-Device Combination Products Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Drug-Device Combination Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Drug-Device Combination Products Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Drug-Device Combination Products Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Drug-Device Combination Products Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Drug-Device Combination Products Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Drug-Device Combination Products Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Drug-Device Combination Products Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Drug-Device Combination Products Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Drug-Device Combination Products Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Drug-Device Combination Products Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Drug-Device Combination Products Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Drug-Device Combination Products Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Drug-Device Combination Products Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Drug-Device Combination Products Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Drug-Device Combination Products Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Drug-Device Combination Products Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Drug-Device Combination Products Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Drug-Device Combination Products Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Drug-Device Combination Products Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Drug-Device Combination Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Drug-Device Combination Products Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Drug-Device Combination Products Market Size by Region (2024-2029) & (US$ Million)
    Table 51. GSK Company Details
    Table 52. GSK Business Overview
    Table 53. GSK Drug-Device Combination Products Product
    Table 54. GSK Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 55. GSK Recent Development
    Table 56. Novo Nordisk Company Details
    Table 57. Novo Nordisk Business Overview
    Table 58. Novo Nordisk Drug-Device Combination Products Product
    Table 59. Novo Nordisk Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 60. Novo Nordisk Recent Development
    Table 61. Eli Lilly Company Details
    Table 62. Eli Lilly Business Overview
    Table 63. Eli Lilly Drug-Device Combination Products Product
    Table 64. Eli Lilly Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 65. Eli Lilly Recent Development
    Table 66. AstraZeneca Company Details
    Table 67. AstraZeneca Business Overview
    Table 68. AstraZeneca Drug-Device Combination Products Product
    Table 69. AstraZeneca Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 70. AstraZeneca Recent Development
    Table 71. Sanofi Company Details
    Table 72. Sanofi Business Overview
    Table 73. Sanofi Drug-Device Combination Products Product
    Table 74. Sanofi Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 75. Sanofi Recent Development
    Table 76. Boston Scientific Company Details
    Table 77. Boston Scientific Business Overview
    Table 78. Boston Scientific Drug-Device Combination Products Product
    Table 79. Boston Scientific Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 80. Boston Scientific Recent Development
    Table 81. Abbott Company Details
    Table 82. Abbott Business Overview
    Table 83. Abbott Drug-Device Combination Products Product
    Table 84. Abbott Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 85. Abbott Recent Development
    Table 86. Boehringer Ingelheim Company Details
    Table 87. Boehringer Ingelheim Business Overview
    Table 88. Boehringer Ingelheim Drug-Device Combination Products Product
    Table 89. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 90. Boehringer Ingelheim Recent Development
    Table 91. Medtronic Company Details
    Table 92. Medtronic Business Overview
    Table 93. Medtronic Drug-Device Combination Products Product
    Table 94. Medtronic Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 95. Medtronic Recent Development
    Table 96. Mylan Company Details
    Table 97. Mylan Business Overview
    Table 98. Mylan Drug-Device Combination Products Product
    Table 99. Mylan Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 100. Mylan Recent Development
    Table 101. 3M Company Details
    Table 102. 3M Business Overview
    Table 103. 3M Drug-Device Combination Products Product
    Table 104. 3M Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 105. 3M Recent Development
    Table 106. Hisamitsu Company Details
    Table 107. Hisamitsu Business Overview
    Table 108. Hisamitsu Drug-Device Combination Products Product
    Table 109. Hisamitsu Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 110. Hisamitsu Recent Development
    Table 111. Smith & Nephew Company Details
    Table 112. Smith & Nephew Business Overview
    Table 113. Smith & Nephew Drug-Device Combination Products Product
    Table 114. Smith & Nephew Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 115. Smith & Nephew Recent Development
    Table 116. Molnlycke Company Details
    Table 117. Molnlycke Business Overview
    Table 118. Molnlycke Drug-Device Combination Products Product
    Table 119. Molnlycke Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 120. Molnlycke Recent Development
    Table 121. Teleflex Company Details
    Table 122. Teleflex Business Overview
    Table 123. Teleflex Drug-Device Combination Products Product
    Table 124. Teleflex Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 125. Teleflex Recent Development
    Table 126. BD Company Details
    Table 127. BD Business Overview
    Table 128. BD Drug-Device Combination Products Product
    Table 129. BD Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 130. BD Recent Development
    Table 131. Lepu Medical Company Details
    Table 132. Lepu Medical Business Overview
    Table 133. Lepu Medical Drug-Device Combination Products Product
    Table 134. Lepu Medical Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 135. Lepu Medical Recent Development
    Table 136. MicroPort Company Details
    Table 137. MicroPort Business Overview
    Table 138. MicroPort Drug-Device Combination Products Product
    Table 139. MicroPort Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 140. MicroPort Recent Development
    Table 141. Terumo Company Details
    Table 142. Terumo Business Overview
    Table 143. Terumo Drug-Device Combination Products Product
    Table 144. Terumo Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 145. Terumo Recent Development
    Table 146. B. Braun Company Details
    Table 147. B. Braun Business Overview
    Table 148. B. Braun Drug-Device Combination Products Product
    Table 149. B. Braun Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 150. B. Braun Recent Development
    Table 151. Antares Pharma Company Details
    Table 152. Antares Pharma Business Overview
    Table 153. Antares Pharma Drug-Device Combination Products Product
    Table 154. Antares Pharma Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
    Table 155. Antares Pharma Recent Development
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug-Device Combination Products Product Picture
    Figure 2. Global Drug-Device Combination Products Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Drug-Device Combination Products Market Size 2018-2029 (US$ Million)
    Figure 4. India Drug-Device Combination Products Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Drug-Device Combination Products Market Size 2018-2029 (US$ Million)
    Figure 6. India Drug-Device Combination Products Market Share in Global 2018-2029
    Figure 7. Drug-Device Combination Products Report Years Considered
    Figure 8. Product Picture of Drug-Coated Device
    Figure 9. Product Picture of Prefilled Drug Delivery Systems
    Figure 10. Product Picture of Nebulizer and Inhaler
    Figure 11. Product Picture of Transdermal Delivery System
    Figure 12. Product Picture of Others
    Figure 13. Global Drug-Device Combination Products Market Share by Type in 2022 & 2029
    Figure 14. Global Drug-Device Combination Products Market Size by Type (2018-2029) & (US$ Million)
    Figure 15. Global Drug-Device Combination Products Market Share by Type (2018-2029)
    Figure 16. India Drug-Device Combination Products Market Share by Type in 2022 & 2029
    Figure 17. India Drug-Device Combination Products Market Size by Type (2018-2029) & (US$ Million)
    Figure 18. India Drug-Device Combination Products Market Share by Type (2018-2029)
    Figure 19. Product Picture of Hospital andClinic
    Figure 20. Product Picture of Retail Pharmacies
    Figure 21. Product Picture of Other
    Figure 22. Global Drug-Device Combination Products Market Share by Application in 2022 & 2029
    Figure 23. Global Drug-Device Combination Products Market Size by Application (2018-2029) & (US$ Million)
    Figure 24. Global Drug-Device Combination Products Market Share by Application (2018-2029)
    Figure 25. India Drug-Device Combination Products Market Share by Application in 2022 & 2029
    Figure 26. India Drug-Device Combination Products Market Size by Application (2018-2029) & (US$ Million)
    Figure 27. India Drug-Device Combination Products Market Share by Application (2018-2029)
    Figure 28. The Top 5 and 10 Largest Companies of Drug-Device Combination Products in the World: Market Share by Drug-Device Combination Products Revenue in 2022
    Figure 29. Global Drug-Device Combination Products Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 30. Global Drug-Device Combination Products Market Share by Region (2018-2029)
    Figure 31. Americas Drug-Device Combination Products Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 32. Americas Drug-Device Combination Products Market Share by Type (2018-2029)
    Figure 33. Americas Drug-Device Combination Products Market Share by Application (2018-2029)
    Figure 34. United States Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Canada Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Mexico Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Brazil Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 38. EMEA Drug-Device Combination Products Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 39. EMEA Drug-Device Combination Products Market Share by Type (2018-2029)
    Figure 40. EMEA Drug-Device Combination Products Market Share by Application (2018-2029)
    Figure 41. Europe Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Middle East Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Africa Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 44. China Drug-Device Combination Products Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 45. China Drug-Device Combination Products Market Share by Type (2018-2029)
    Figure 46. China Drug-Device Combination Products Market Share by Application (2018-2029)
    Figure 47. APAC Drug-Device Combination Products Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 48. APAC Drug-Device Combination Products Market Share by Type (2018-2029)
    Figure 49. APAC Drug-Device Combination Products Market Share by Application (2018-2029)
    Figure 50. Japan Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 51. South Korea Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 52. China Taiwan Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Southeast Asia Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 54. India Drug-Device Combination Products Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 55. GSK Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 56. Novo Nordisk Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 57. Eli Lilly Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 58. AstraZeneca Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 59. Sanofi Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 60. Boston Scientific Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 61. Abbott Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 62. Boehringer Ingelheim Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 63. Medtronic Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 64. Mylan Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 65. 3M Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 66. Hisamitsu Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 67. Smith & Nephew Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 68. Molnlycke Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 69. Teleflex Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 70. BD Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 71. Lepu Medical Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 72. MicroPort Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 73. Terumo Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 74. B. Braun Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 75. Antares Pharma Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Automatic Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8S20198
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Optically Clear PCR Strip Tubes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1L20132
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Avena Sativa Kernel Meal Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28Q19902
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions